Daniel J. Anderson

О себе

Daniel J. Anderson, Ph.D. is a biotechnology R&D executive focused on drug discovery and translational science. In January 2026, he was appointed Chief Scientific Officer of Integrated Biosciences, where he leads scientific strategy for small-molecule therapeutics targeting age-related diseases. Previously, he served as CSO at Eikon Therapeutics and held biology leadership roles at Recursion Pharmaceuticals, Cleave Biosciences, and Genentech.

Области интересов